Generics - Generics, Antibiotics and Infectious diseases


Popular Filters

1 to 25 of 31 results

ANI Pharma acquires Vancocin assets from Shire

ANI Pharma acquires Vancocin assets from Shire


US generic drugmaker ANI Pharmaceuticals says it has acquired the US rights for the antibiotic Vancocin…

ANI PharmaceuticalsAntibiotics and Infectious diseasesEli Lilly and CompanyGenericsGlycopeptide antibioticsIrelandMergers & AcquisitionsNew DrugShireUSAVancocinVancomycin HCl

South Africa regulator gives MSF access to cheaper TB drug linezolid

South Africa regulator gives MSF access to cheaper TB drug linezolid


After a three-year long struggle, humanitarian aid agency Medecins Sans Frontieres has received approval…

Antibiotics and Infectious diseasesGenericsHealthcareLinezolidPfizerRegulationSouth AfricaZyvox

Drug pricing power led by hepatitis C, diabetes and cancer

Drug pricing power led by hepatitis C, diabetes and cancer


Hepatitis C, diabetes and cancer are sustaining high pricing power through innovation according to Morningstar's…

AbbVieAntibiotics and Infectious diseasesBiogen IdecCopaxoneDiabetesGenericsGilead SciencesMerck & CoOncologyPharmaceuticalPricingTecfideraTeva Pharmaceutical IndustriesUSA

High incidence and inadequate treatments boost prospects of HIV, Chagas, Dengue and influenza H1N1 drugs in Latin America

High incidence and inadequate treatments boost prospects of HIV, Chagas, Dengue and influenza H1N1 drugs in Latin America


The high incidence of human immunodeficiency virus (HIV), Chagas, dengue and influenza H1N1, as well…

Anti-viralsAntibiotics and Infectious diseasesGenericsMarkets & MarketingPharmaceuticalSouth America

Mylan pushes further into India, introducing critical care segment

Mylan pushes further into India, introducing critical care segment


US generics major Mylan says its Indian subsidiary has launched a Critical Care segment in India. The…

AmbisomeAntibiotics and Infectious diseasesAsia-PacificGenericsIndiaMarkets & MarketingMylan Laboratories

Sandoz to commercialize Taiwan Liposome’s antifungal

Sandoz to commercialize Taiwan Liposome’s antifungal


Taipei-based biopharmaceutical company Taiwan Liposome Company has entered into a collaboration agreement…

Amphotericin BAntibiotics and Infectious diseasesAsia-PacificGenericsLicensingNovartisSandozTaiwan Liposome

Recipharm files for European approval of first-in class generic anti-infective


Swedish contract development and manufacturing group Recipharm says its subsidiary RPH Pharmaceuticals…

Antibiotics and Infectious diseasesAstimex PharmaEuropeGenericsRecipharmRegulationRPH Pharmaceuticals

US FDA approves Teva’s generic TOBI

US FDA approves Teva’s generic TOBI


Teva Pharmaceutical Industries says that the US Food and Drug Administration has granted approval of…

Antibiotics and Infectious diseasesGenericsNovartisRare diseasesRegulationTeva Pharmaceutical IndustriesTobi

Mylan launches first generic of Pfizer antifungal

Mylan launches first generic of Pfizer antifungal


Mylan says it has launched voriconazole for oral suspension, which is the first generic version of Pfizer's…

Antibiotics and Infectious diseasesGenericsMarkets & MarketingMylan LaboratoriesNorth AmericaPfizerVfend

Bayer in settlement over Cipro pricing


A partial settlement has been reached in a US class action law suit involving the prescription antibiotic…

Antibiotics and Infectious diseasesBayerCiproGenericsLegalNorth AmericaPharmaceuticalPricing

$200+ billion annual opportunity in USA from using medicines more responsibly, IMS finds


Avoidable costs of more than $200 billion are incurred each year in the US health care system as a result…

Antibiotics and Infectious diseasesDiabetesFinancialGenericsHealthcareNorth AmericaPharmaceutical

UNITAID market power results in price cuts of up to 80% for HIV/AIDS, TB and malaria products


UNITAID's approach to transform health product markets has delivered price reductions of up to 80% for…

Anti-viralsAntibiotics and Infectious diseasesGenericsGlobalHealthcarePharmaceuticalPricingTropical diseases

Novo A/S acquires Norway's Xellia Pharmaceuticals in $700 million deal


Denmark-based Novo A/S, the holding company of the Novo Group and the major shareholder in Novo Nordisk…

Antibiotics and Infectious diseasesGenericsMergers & AcquisitionsNovo A/SNovo NordiskPharmaceuticalXellia Pharmaceuticals

Actavis pays Valeant $55M for drug rights; Incyte gets $25M milestone


US generics major Actavis (NYSE: ACT), reportedly the subject of a stalled takeover bid from Canada's…

ActavisAntibiotics and Infectious diseasesFinancialGenericsINC280IncyteLicensingMetronidazole LotionNovartisOncologyPharmaceuticalResearchValeant Pharmaceuticals

Russia's Rafarma Pharmaceuticals increases product range


Rafarma Pharmaceuticals (Pinksheets: RAFA), a Russia-based multi-product pharmaceutical company producing…

Antibiotics and Infectious diseasesceftriaxoneEuropeGenericsMarkets & MarketingRafarma Pharmaceuticals

Anti-infective market in sub-Saharan Africa set to reach $377 million in 2018


The high incidence of infectious diseases in sub-Saharan Africa is expected to sustain the demand for…

Antibiotics and Infectious diseasesGenericsMarkets & MarketingPharmaceuticalRest of the World

DCC Healthcare acquires generic drugmaker Kent Pharma


Dublin, Ireland-based sales, marketing, distribution and business support services group DCC, says that…

Antibiotics and Infectious diseasesDCC HealthcareGenericsKent PharmaceuticalMergers & Acquisitions

India's Macleods Pharma to invest $25 million in production in Russia; Ferring to start manufacturing


Indian drugmaker Macleods plans to invest up to 700 million roubles (around $25 million) in the construction…

Antibiotics and Infectious diseasesEuropeFerring PharmaceuticalsGenericsIzvarino PharmaMacleods PharmaceuticalsOncologyPharmaceuticalProduction

Major constraints in the hospital-treated infections drug market include generic erosion


The hospital-treated infections (HTI) drug market, the loss of patent protection for key branded products…

Antibiotics and Infectious diseasesGenericsGlobalMarkets & MarketingPharmaceuticalResearch

US FDA pulls 27 Ranbaxy ANDAs approvals under consent decree


The Food and Drug Administration is withdrawing approval of 27 Abbreviated New Drug Applications (ANDAs)…

Antibiotics and Infectious diseasesDaiichi SankyoDiabetesGenericsNorth AmericaRanbaxy LaboratoriesRegulation

UK's NICE launches new medicines advisory service


The UK drugs watchdog the National Institute for Health and Clinical Excellence (NICE) last Friday launched…

Antibiotics and Infectious diseasesAstellas PharmaBiotechnologyDificlirEuropeGenericsPharmaceuticalRegulation

Teva settles Nuvigil patent litigation with Mylan, which debuts generic Doryx


Israel-based Teva Pharmaceutical Industries (Nasdaq: TEVA), the world's largest generics companies, said…

Antibiotics and Infectious diseasesDoryxGenericsLegalMergers & AcquisitionsMylan LaboratoriesNeurologicalNorth AmericaNuvigilPatentsPharmaceuticalTeva Pharmaceutical IndustriesWarner Chilcott

1 to 25 of 31 results

Back to top